orBec beclomethasone dipropionate regulatory update

Dor BioPharma said it withdrew an MAA for orBec beclomethasone to treat gastrointestinal graft-versus-host disease (GvHD) after EMEA requested additional clinical trials to demonstrate efficacy of the...